Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23204872)

1.

Vaginal rings for delivery of HIV microbicides.

Malcolm RK, Fetherston SM, McCoy CF, Boyd P, Major I.

Int J Womens Health. 2012;4:595-605. doi: 10.2147/IJWH.S36282. Epub 2012 Nov 20.

2.

Recent work on vaginal rings containing antiviral agents for HIV prevention.

Spence P, Bhatia Garg A, Woodsong C, Devin B, Rosenberg Z.

Curr Opin HIV AIDS. 2015 Jul;10(4):264-70. doi: 10.1097/COH.0000000000000157.

PMID:
26049952
3.

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: a Double-Blind Randomized Trial.

Chen BA, Panther L, Marzinke MA, Hendrix CW, Hoesley CJ, van der Straten A, Husnik MJ, Soto-Torres L, Nel A, Johnson S, Richardson-Harman N, Rabe LK, Dezzutti CS.

J Acquir Immune Defic Syndr. 2015 May 28. [Epub ahead of print]

PMID:
26034880
4.

A temperature-monitoring vaginal ring for measuring adherence.

Boyd P, Desjardins D, Kumar S, Fetherston SM, Le-Grand R, Dereuddre-Bosquet N, Helgadóttir B, Bjarnason Á, Narasimhan M, Malcolm RK.

PLoS One. 2015 May 12;10(5):e0125682. doi: 10.1371/journal.pone.0125682. eCollection 2015.

5.

Recent advances on anti-HIV vaginal delivery systems development.

Antimisiaris SG, Mourtas S.

Adv Drug Deliv Rev. 2015 Apr 7. pii: S0169-409X(15)00054-X. doi: 10.1016/j.addr.2015.03.015. [Epub ahead of print] Review.

PMID:
25858666
6.

The Sheep as a Model of Preclinical Safety and Pharmacokinetic Evaluations of Candidate Microbicides.

Holt JD, Cameron D, Dias N, Holding J, Muntendam A, Oostebring F, Dreier P, Rohan L, Nuttall J.

Antimicrob Agents Chemother. 2015 Jul;59(7):3761-70. doi: 10.1128/AAC.04954-14. Epub 2015 Apr 6.

PMID:
25845860
7.

Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine.

Kaur M, Gupta KM, Poursaid AE, Karra P, Mahalingam A, Aliyar HA, Kiser PF.

Drug Deliv Transl Res. 2011 Jun;1(3):223-37. doi: 10.1007/s13346-011-0027-1.

PMID:
25788241
8.

Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.

Friend DR.

Drug Deliv Transl Res. 2011 Jun;1(3):185-93. doi: 10.1007/s13346-011-0024-4.

PMID:
25788239
9.

Lack of in vitro-in vivo correlation for a UC781-releasing vaginal ring in macaques.

McConville C, Smith JM, McCoy CF, Srinivasan P, Mitchell J, Holder A, Otten RA, Butera S, Doncel GF, Friend DR, Malcolm RK.

Drug Deliv Transl Res. 2015 Feb;5(1):27-37. doi: 10.1007/s13346-015-0216-4.

PMID:
25787337
10.

Development of a UC781 releasing polyethylene vinyl acetate vaginal ring.

McConville C, Major I, Friend DR, Clark MR, Malcolm RK.

Drug Deliv Transl Res. 2012 Dec;2(6):489-97. doi: 10.1007/s13346-012-0101-3.

PMID:
25787327
11.

Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer.

Boyd P, Major I, Wang W, McConville C.

Eur J Pharm Biopharm. 2014 Nov;88(3):945-53. doi: 10.1016/j.ejpb.2014.08.002. Epub 2014 Aug 13.

PMID:
25128854
12.

A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.

Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N.

AIDS. 2014 Jun 19;28(10):1479-87. doi: 10.1097/QAD.0000000000000280.

PMID:
24901365
13.

Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.

Murphy DJ, Desjardins D, Dereuddre-Bosquet N, Brochard P, Perrot L, Pruvost A, Le Grand R, Lagatie O, Vanhooren L, Feyaerts M, van Roey J, Malcolm RK.

J Antimicrob Chemother. 2014 Sep;69(9):2477-88. doi: 10.1093/jac/dku160. Epub 2014 May 26.

PMID:
24862093
14.

Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Thurman AR, Clark MR, Hurlburt JA, Doncel GF.

Int J Womens Health. 2013 Oct 21;5:695-708. doi: 10.2147/IJWH.S34030. Review.

15.

A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.

Fetherston SM, Boyd P, McCoy CF, McBride MC, Edwards KL, Ampofo S, Malcolm RK.

Eur J Pharm Sci. 2013 Feb 14;48(3):406-15. doi: 10.1016/j.ejps.2012.12.002. Epub 2012 Dec 21.

PMID:
23266465
16.

Microbicides and HIV: A Review and an update.

Naswa S, Marfatia YS, Prasad TL.

Indian J Sex Transm Dis. 2012 Jul;33(2):81-90. doi: 10.4103/0253-7184.102098.

17.

A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine.

Major I, Boyd P, Kilbourne-Brook M, Saxon G, Cohen J, Malcolm RK.

Contraception. 2013 Jul;88(1):58-66. doi: 10.1016/j.contraception.2012.10.018. Epub 2012 Nov 21.

PMID:
23177261
18.

In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.

Grammen C, Augustijns P, Brouwers J.

Antiviral Res. 2012 Nov;96(2):226-33. doi: 10.1016/j.antiviral.2012.09.011. Epub 2012 Sep 20.

PMID:
23000496
19.

Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1.

Buckheit KW, Buckheit RW Jr.

Mol Biol Int. 2012;2012:781305. doi: 10.1155/2012/781305. Epub 2012 Jul 12.

20.

Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides.

Fetherston SM, Malcolm RK, Woolfson AD.

Ther Deliv. 2010 Dec;1(6):785-802. Review.

PMID:
22834014
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk